Spectrum Pharmaceuticals, Inc. (SPPI) Tops Q3 EPS by 13c

November 7, 2012 7:34 AM EST
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q3 EPS of $0.42, $0.13 better than the analyst estimate of $0.29. Revenue for the quarter came in at $69 million versus the consensus estimate of $68.56 million.

For earnings history and earnings-related data on Spectrum Pharmaceuticals, Inc. (SPPI) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings